-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
For medical professionals only
What are the important guidance updates in the digestive area in 2022? Let's take a |
of writing MSHK
1
New guidelines in the field of gastroesophageal reflux disease1.
American College of Gastroenterology (ACG) guidelines: clinical diagnosis and treatment of gastroesophageal reflux disease (GERD).
In recent years, the incidence of gastroesophageal reflux (GERD) in Asia has gradually increased, and in severe cases, it will affect the quality of life of
patients.
In January 2022, ACG published clinical diagnosis and treatment guidelines for GERD in The American Journal of GASTROENTEROLOGY, which is the second update
of ACG since 2013.
This guideline provides up-to-date clinical recommendations for the evaluation and management of GERD, including the diagnosis of GERD, management of GERD, extraesophageal GERD, refractory GERD, and surgical and endoscopic management of GERD
.
If you want to see the detailed guide interpretation, poke the following link 👇:
How to treat gastroesophageal reflux that plagues most people? ACG Guidelines Update after 7 years!
2.
"Chinese Multidisciplinary Diagnosis and Treatment Consensus of Gastroesophageal Reflux Disease 2022"
GERD is a multidisciplinary disease, the Gastroesophageal Reflux Disease Branch of the China Association for the Promotion of International Exchanges in Healthcare has updated the "Chinese Multidisciplinary Diagnosis and Treatment Consensus on Gastroesophageal Reflux Disease" based on the current multidisciplinary development status of GERD in China and a large number of clinical and research progress since the first edition of the "Chinese Multidisciplinary Diagnosis and Treatment Consensus on Gastroesophageal Reflux Disease", and the new version of the consensus elaborates on 10 parts such as the pathogenesis, clinical manifestations, diagnosis and treatment of GERD, which is comprehensive and detailed , practical
.
If you want to see the interpretation of detailed guidelines, poke the following link 👇:
"China Multidisciplinary Diagnosis and Treatment Consensus of Gastroesophageal Reflux Disease 2022" is released! These points are not to be missed
2
New guidelines in the field of colorectal cancer1.
Expert Consensus on Treatment Strategies for Precancerous Lesions and Precancerous Conditions in Colorectal Cancer in China (2022).
Colorectal cancer (CRC) is one of the most common gastrointestinal malignant tumors in China, and the latest data from the International Agency for Research on Cancer shows that the number of new cases of CRC in China in 2020 is expected to be 555,000
.
In recent years, the incidence and mortality of CRC in China have been on the rise
.
In order to reduce the incidence and mortality of CRC in China, the National Clinical Research Center for Digestive Diseases led a number of consensus discussions and formulated the Expert Consensus on Treatment Strategies for Precancerous Lesions and Precancerous States of Colorectal Cancer in China (2022), which includes the definition, prevention, screening and diagnosis, and treatment of precancerous lesions and states of colorectal cancer
.
Want to see the detailed guide interpretation, poke the following link 👇:
"precancerous lesions" before the advent of bowel cancer, how should it be diagnosed and treated? The latest expert consensus recommends.
.
.
.
2.
Asia-Pacific Working Group on Colorectal Cancer Screening: Guidelines for CRC Screening and Post-Polypectomy Surveillance
Asia Pacific has the highest burden of CRC incidence (51.
8%) and mortality (52.
4%) in the world, with some of the highest incidence countries, including Australia, New Zealand, China, Japan and South Korea
.
In August this year, the Asia-Pacific Working Group on Colorectal Cancer Screening published the latest Guidelines for CRC Screening and Post-Polypectomy Surveillance in the prestigious journal GUT, which updates and revises recommendations on screening methods and preferred strategies, age to start and stop screening for colorectal cancer, screening individuals with a family history of colorectal cancer or advanced adenomas, monitoring adenoma patients, screening and monitoring for pedicle-serrated lesions
。
Want to see the detailed guide interpretation, poke the link 👇 below:
Should polyps be cut? When is colorectal cancer screening? The 2022 latest guide says so
3
New guidelines in the field of liver disease1.
Australasian Gastroenterology Society (GESA) Guidelines: Recommendations for the Management of Hepatitis B
In recent years, the incidence of hepatitis B (HBV) has gradually increased, and in severe cases, it will affect the quality of life of
patients.
In March, GESA published recommendations
for the management of hepatitis B in The Medical Journal of Australia.
Compared with the previous version, the guidelines are more accurate and more detailed in all aspects, and some new normative standards have been promulgated to improve the current understanding of hepatitis B management, including the identification of hepatitis B patients, the timing of initiation of antiviral therapy, and the management of hepatitis B reactivation in immunocompromised patients
.
To see the detailed guideline interpretation, poke the link 👇 below:
How is hepatitis B treated? GESA guidelines updated after 13 years!
2.
American Association for the Study of Liver Diseases (AASLD) Guidelines: Guidelines for the Management of Drug-induced Liver Injury (DILI).
The incidence of DILI is 1.
4%~8.
1%, accounting for 20%~50% of non-viral liver disease, which is one of the most common adverse drug reactions in clinical practice and should be paid attention to
.
This year, AASLD issued guidelines for the management of DILI, which provide clinical recommendations
on the classification, diagnosis, and management of DILI.
Want to see the detailed guideline interpretation, poke the following link 👇:
How to diagnose and manage drug-induced liver injury? This article summarizes the highlights of the latest guidance updates
3.
Italian Society of Hepatology (AISF) Guidelines: 2022 Clinical Practice Guidelines for Benign Liver Lesions
, usually have no clinical manifestations, and are less harmful to the human body than malignant lesions, but some benign lesions in the liver can cause abdominal pain, vomiting, jaundice and other symptoms, and can compress the gastrointestinal tract, seriously affecting the quality of life of
patients.
Therefore, timely and effective treatment is essential
.
In 2022, AISF issued the latest guidelines for benign liver lesions, and put forward constructive opinions
on the diagnosis and treatment of cystic lesions and substantive lesions of the liver.
If you want to see a detailed guide interpretation, poke the link 👇 below:
What to do if you find a liver cyst? The 2022 new edition of the guide teaches you to do this
, what to do if you find a benign tumor of the liver? The 2022 new version of the guide gives 10 recommendations
4
Other digestive area guidelines1.
Guidelines for the diagnosis and treatment of gastric cancer in China (2022 edition).
According to the latest data from China in 2020, gastric cancer incidence and mortality ranked third
among various malignant tumors.
China accounts for about 40%
of the approximately 1.
2 million new cases of gastric cancer worldwide each year.
The proportion of early gastric cancer in China is very low, only about 20%, most of which are found in the advanced stage, and the overall 5-year survival rate is less than 50%.
In recent years, with the popularization of gastroscopy, the proportion of early gastric cancer has increased year by year
.
In April this year, the "Guidelines for the Diagnosis and Treatment of Gastric Cancer (2022 Edition)" released on the official website of the National Health Commission gave detailed suggestions
on the diagnosis, pathological classification, staging and treatment of gastric cancer.
If you want to see the interpretation of the detailed guidelines, poke the link 👇 below:
The National Health Commission released the latest gastric cancer diagnosis and treatment guidelines, and the updated content was sent quickly!
2.
Clinical Practice Guidelines for the Assessment and Surgical Management of Chronic Constipation in Adults in China
Chronic constipation has become an important factor
affecting people's quality of life.
With the continuous improvement of living standards and the aggravation of the aging trend of China's population, the prevalence of chronic constipation has shown a significant upward trend, and the abuse of constipation drugs in China is very serious, which is currently a difficult clinical problem
.
In January this year, the Colorectal Surgery Group of the Surgical Branch of the Chinese Medical Association issued the "Clinical Practice Guidelines for the Evaluation and Surgical Management of Chronic Constipation in Adults in China", which puts forward specific suggestions
for the diagnosis, evaluation and treatment of constipation based on the common problems in the clinical assessment and management of constipation (non-surgical management and surgical treatment).
If you want to see the detailed guide interpretation, poke the link 👇 below:
Nearly 1.
5 billion people around the world suffer from constipation, the latest guide teaches you to start a happy life!
The web version of the doctor's station is online
Scan the QR code to directly view more clinical knowledge of gastroenterology and hepatology
👇👇👇This article reviewed: Yang Health Deputy Chief Physician of Jingdezhen Second People's Hospital Responsible Editor: Wen Jiaxin
- End -* "Medical Community" strives to publish professional and reliable content, but does not make a commitment to the accuracy of the content; Relevant parties are requested to check
separately when adopting or using it as a basis for decision-making.
Call for papers: Medical Digestive Liver Disease Channel welcomes your submissions! Click the link below or scan the QR code to submit: https://titan.
yishengzhan.
cn/#/public_contribution please fill in the real information according to the submission interface
↓↓↓ Click "Read Original" to learn more clinical skills
